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SUPPLEMENTAL EXPERIMENTAL SECTION 
Materials and characterization of the silver particles  
Silver particles (designated as AgNP, and Ag Bulk) were purchased from Nanostructured 
and Amorphous Materials Inc., Houston, USA. Based on the manufacturers specifications, 
AgNP were spherical particles of average size 10 nm, with a specific surface area of 9–11 
m
2
/g, bulk density of 2.05 g/cm
3
 and a true density of 10.5 g/cm
3
, and had a purity of 99.9%, 
based on trace metal analysis. Bulk silver particles had an average particle size of 0.6–1.6 µm 
and purity of 99.95%. Silver with 2% HNO3 was obtained from PerkinElmer Life and 
Analytical Sciences, Connecticut, USA. The characterization of the exposure particles has 
been described previously [1] in which particle size, shape and charge were established using 
(high resolution) transmission electron microscopy (HRTEM), atomic force microscopy 
(AFM), X-ray electron dispersive spectroscopy (X-EDS), X-ray diffraction (XRD), dynamic 
light scattering (DLS) and the Braun Emmett Teller (BET) method of specific surface area 
analysis. In summary, the AgNP had the most negative average zeta potential value (-12.5 
mV) and formed aggregates of 589 ± 101nm (measured by Dynamic Light Scattering [DLS]). These 
particles had a polydispersity index of 0.54, indicating relatively uniform aggregate sizes. 
The average zeta potential for Ag Bulk was -2.8 mV, and these particles formed aggregates 
of 938 ± 230nm (DLS) and had a polydispersity index of 0.69. Electron microscopy images 
confirmed the potential of the particles to aggregate and further details of the characterization 
of these particles are given in [1]. 
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Assessment of the dissolution of silver particles in exposure medium 
AgNP and Ag Bulk were dissolved in ultrapure water as described in the main manuscript. 
Four beakers were set up with 800 mL of artificial water, prepared according to the ISO 
7346-3:1996 guideline and placed on a magnetic stirrer. Four sealed dialysis membranes 
(Dialysis membrane Spectra/Por 7, Fisher), filled with10 mL of artificial water were added to 
each beaker. At the start of the experiment, an appropriate volume of AgNP and Ag Bulk 
stock solution was added to each beaker to obtain a final concentration of 5 µg silver 
material/L (2 replicate beakers for each treatment) and the solutions were stirred continuously 
for 24h, at a constant temperature of 28
o
C. The solution contained within a dialysis 
membrane from each treatment replicate was sampled at 3, 6, 12 and 24h and acidified with 
2% of nitric acid for determination of the concentration of Ag
+
 inside the membrane, 
corresponding to the dissolved Ag
+
 originating from the Ag particles. Ag content in the water 
samples was measured using a Thermo Scientific, X Series 2 ICP-MS instrument at the  
 Analytical Research Facility (ARF), University of Plymouth, UK. 
 
Embryo exposures for determination of toxicological effects in zebrafish embryos 
Zebrafish embryos were exposed to a range of concentrations of Ag
+
 (0.0122 to 100 µg/L) 
AgNP (3.9 to 8000 µg/L) and Ag Bulk (3.9 to 8000 µg/L) in order to determine the mortality 
curves for each form of silver. Exposure chambers (600 mL) received 400 mL of ISO water 
containing the appropriate concentration of Ag
+
, AgNP, or Ag Bulk. Twenty fertilized 
embryos were deployed into each treatment chamber and including control chambers which 
received water alone. Exposure chambers which incubated in a water bath at 28 ± 1°C with a 
12h light:dark photoperiod, ensuring consistency in the exposures for all treatments. 
Exposures were initiated at 4hpf, and the water was changed completely 24h after the start of 
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the exposure. Embryo mortalities were determined at 24h and 48h after the start of the 
chemical exposure by visual inspection using light microscopy (Kyowa Optical SDZ PL, 
Kyowa Optical, Japan) and any dead embryos were removed from the exposure chambers. 
The experiment was terminated 48h after the start of the chemical exposures by humanely 
sacrificing the remaining embryos. 
 
Embryo exposures for investigations into the effects of Ag
+
 on oxygen consumption  
Zebrafish embryos were exposed to a range of concentrations of Ag
+
 and including those 
expected to be present in the water as a consequence of dissolution following exposure to 
AgNP, Ag Bulk and Ag
+
 (0, 0.031, 0.062, 0.125, 0.250, 0.500, 1 and 5 µg Ag
+
/L). Exposure 
chambers received 500 mL of ISO water containing the appropriate concentration of Ag
+
. 
Groups of 5 fertilized embryos were deployed into individual glass vials, filled with exposure 
water and capped under water to ensure complete displacement of any air in the vials. For 
each treatment, 6 vials were set up, and incubated within the exposure chambers, placed in a 
water bath at 25.5
o
C, to ensure consistency in exposure temperatures for all treatments, and a 
vial without embryos was also included as a control for the oxygen measurements. Exposures 
were initiated at 4hpf, and exposure water was changed completely after 24h. Concentration 
of oxygen was determined in the chambers and individual vials at 24 and 48h of exposure 
using a Strathkelvin Instruments Oxygen Meter, model 781. In this way, oxygen consumption 
could be determined for individual embryos, using the measurements of volume of individual 
vials, incubation time and difference in oxygen partial pressure (PO2) between the exposure 
water without embryos and the exposure vials. Water PO2 was converted to oxygen content 
using the equation (0.0000017361*(T^3)) + (0.0004068*(T^2)) - (0.0515611*(T)) + 
2.6779143, derived from tabulated values for the oxygen solubility coefficient in water of 
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zero salinity, in which T was the temperature of each chamber [2]. Oxygen consumption 
(MO2) was then calculated using the Fick principle, according to the equation MO2 = (water 
volume x ∆O2) / (number of embryos x time period). The experiment was terminated 
following 48 h of exposure. 
 
HT-SuperSAGE library construction 
Illumina compatible adapters used in this experiment were kindly provided by Dr 
Matsumura (Iwate Biotechnology Research Center, Kitakami, Japan). Double-stranded 
cDNA was synthesized from 5–10 µg of total RNA, primed with a poly-T biotinylated 
adapter containing the NlaIII recognition site and using the SuperScript II double-stranded 
cDNA synthesis kit (Invitrogen). Purified cDNA was digested with the anchoring enzyme 
NlaIII, and the resulting fragments were bound to beads coated with streptavidin (Dynabeads 
streptavidin M-270), while non-biotinylated cDNA fragments were removed. A double 
stranded adaptor containing the EcoP151 recognition site and 3’ overhang complementary to 
the NlaIII restriction site was ligated to the cDNA fragments, bound to beads and digested 
with EcoP151. Following digestion, released fragments were ligated to a second double 
stranded adapter complementary to the EcoP151 overhang and containing motifs for flowcell 
binding, priming the sequencing reaction and a 4 nucleotide barcode index for sample 
identification. Tagged fragments were amplified via PCR in 8-15 reactions per library. PCR 
products were pooled, concentrated using a MinElute reaction purification kit (Qiagen) and 
analysed on an 8% non-denaturing polyacrylamide gel. Visualization of amplicons stained 
with SYBR green (Invitrogen) was followed by excision and purification of a band 
corresponding to 123-125bp. The purified PCR product for each sample was analyzed using 
an Agilent Bioanalyser 2100 for accurate sizing and quantification. Equimolar concentrations 
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of the PCR products for each sample were pooled in groups of 3 or 4, and libraries were 
sequenced using an Illumina Genome Analyzer (GA) II platform.  
All proprietary products were used according to manufacturer’s instructions. Library 
preparation reaction parameters were used as described elsewhere [3]. 
 
SUPPLEMENTAL RESULTS AND DISCUSSION 
Assessment of the dissolution of silver particles in exposure medium 
The dissolution rates for AgNP and Ag Bulk were variable and ranged from below the 
detection limit of the method (0.001 µg/L) to 0.7% and 0.6% for AgNP and Ag Bulk, 
respectively. There was no clear association of the dissolution rates with time, suggesting that 
most of the dissolution may have occurred during the initial suspension of the particles in 
water, which involved a period of sonication. The average dissolution rate was 0.27 ± 0.15% 
and 0.27 ± 0.07% for AgNP and Ag Bulk, respectively. 
 
Toxicological effects of exposure to Ag
+
, AgNP and Ag Bulk in zebrafish embryos  
Exposure to Ag
+
, AgNP and Ag Bulk caused mortalities to zebrafish embryos in a dose 
response manner (Figure S1). The LC50 concentrations were 19.2, 1912.8 and 2043.4 µg/L 
of Ag
+
, AgNP and Ag Bulk, respectively. Based on this data, the concentrations selected for 
the molecular analysis of the mechanisms of toxicity of the three forms of silver were far 
below those causing overt toxicity in our experimental conditions. 
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HT-SuperSAGE data analysis  
The number of sequences obtained for each library ranged from 1.2 million (48 hpf AgNP) 
to 2.2 million (24 hpf AgNP) and the abundance distributions of these sequence tags were 
generally consistent between all libraries (Table S1). Importantly, despite some variation in 
the number of tags sequenced per treatment group, the numbers of tags corresponding to 
relatively abundant classes were highly consistent across treatments, and the variable 
numbers of tags were found to fall within the group of tags which were sequenced only once 
per sample. In total, 13,680,994 sequences were taken further for analysis and these were 
represented by 606,259 unique sequence tags (unitags). A total of 205,033 unitags were 
sequenced more than once across all treatments (with a total of 13,279,768 counts). Between 
29 and 40% of the unitags (401,226) were sequenced only once across all treatments (referred 
to in this paper as singletons), but these accounted for only between 2-3% of the total number 
of sequences obtained (Table S1; Figure 1). This is consistent with other studies that 
employed the SuperSAGE methodology, although in these studies singletons were referred to 
as tags that were sequenced only once per sample as opposed to once across all treatments [4-
7]. It cannot be excluded that some singletons may represent low-abundance transcripts or be 
the result of PCR/sequencing errors. However, singletons were included in the downstream 
analyses to avoid losing information from low-abundance transcripts. 
In total 99,683 unitags aligned to zebrafish genes, with 77,821 of these mapping to unique 
genes only (7,690,269 counts in total) and representing 14,793 genes (Figure 1). This is 
consistent with previous studies that reported a similar number of expressed genes in 
embryos at similar stages of development using zebrafish Affymetrix microarrays 
(ArrayExpress database [http://www.ebi.ac.uk/arrayexpress/]; Experiment ID: E-TABM-33) 
or RNAseq [8]. About 20 percent of the unitags (21,872) and with a total of 221,592 counts 
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(3% of the total unitag counts), also mapped to antisense gene sequences, which has been 
observed previously in other tag-based gene expression studies [9-11]. Approximately 80% 
of the genes were represented by more than one unitag (see Figure S2), consistent with other 
studies that are based on SAGE methods, which is likely the result of incomplete NlaIII 
digestion during the library preparations, alternative polyadenylation and/or alternative 
splicing sites [12-14]. 
 
Comparison with previous microarray study 
We compared our gene expression data for controls (non-exposed) with previous 
(unpublished) data for zebrafish embryos at 24 and 48h of development obtained using 
zebrafish Affymetrix microarrays (downloaded from the ArrayExpress database; Experiment 
ID E-TABM-33). A comparison of the ratios of expression values of all genes for which data 
were available for both platforms and for both time points (48 hpf /24 hpf) identified a strong 
correlation between the datasets (r  = 0.714; P < 0.0001; n = 4951) . In addition, we identified 
a group of genes (48 in total) that were expressed at 24h but not at 48h both in our 
experiments and the microarray dataset (see File S4). Many of these genes are likely to be 
maternally expressed genes and not transcribed during embryogenesis. As such, these genes 
were expected not to be regulated by the chemical exposures and indeed, we confirmed that 
none of these putative maternally expressed genes were differentially expressed for any 
treatment or time point. Conversely, a number of genes (77 in total) were only found to be 
expressed at 48hpf and these were predominantly involved with eye, brain and muscle 
development (organs known to develop during later stages of embryogenesis in zebrafish; 
[15]; File S4). Together, these findings support that our measurements and data analysis are 
highly robust. 
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SUPPLEMENTAL FIGURES AND TABLES 
 
Figure S1 – Mortality curves for zebrafish embryos exposed to Ag
+
, AgNP and Ag Bulk 
for 48h (between 4 and 52h post fertilization). Closed circles, closed triangles and open 
circles represent mortality data following exposure to Ag
+
, AgNP and Ag Bulk, respectively. 
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Table S1 – Properties of the HT-SuperSAGE libraries from control and silver-treated zebrafish embryos. 
For each library, the sequence tag abundance, the number of unique sequence tags (unitags) and the total number of sequence tags are given. 
 
Control Silver NP Silver bulk Silver ions Control Silver NP Silver bulk Silver ions
Copies million
-1
>10,000 6                    9                    12                  13                  10                  12                  11                  14                  
1,000-10,000 77                  82                  85                  107               95                  103               92                  99                  
100-1,000 509               648               609               585               617               700               623               684               
10-100 4,431            5,527            4,834            3,940            5,343            5,820            5,165            5,593            
1-10 15,408          17,493          16,058          13,631          16,515          17,170          15,509          15,368          
≤1 126,117        157,429        95,317          63,417          137,620        87,100          132,155        135,446        
Total 146,548        181,188        116,915        81,693          160,200        110,905        153,555        157,204        
Non-singletons 88,939          109,620        75,346          58,044          96,539          76,559          100,346        101,589        
Singletons 57,609          71,568          41,569          23,649          63,661          34,346          53,209          55,615          
% Singletons 39% 39% 36% 29% 40% 31% 35% 35%
Total 146,548        181,188        116,915        81,693          160,200        110,905        153,555        157,204        
Non-singletons 1,801,130    2,167,248    1,170,904    1,336,753    1,604,740    1,154,977    2,083,712    1,960,304    
Singletons 57,609          71,568          41,569          23,649          63,661          34,346          53,209          55,615          
% Singletons 3% 3% 3% 2% 4% 3% 2% 3%
Total 1,858,739    2,238,816    1,212,473    1,360,402    1,668,401    1,189,323    2,136,921    2,015,919    
Total number of sequences
 24h post-fertilisation  48h post-fertilisation
Sequence abundance
Number of unitags
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Figure S2 – Mapping of sequences to genes. The number of genes represented by multiple sequence tags (number of tags per gene are indicated on the x-
axis and the number of genes are indicated in the y-axis). 
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Figure S3 – Gene expression correlation between the different silver treatment libraries and the time-matched control libraries. Coloured dots indicate 
individual genes (total normalized counts for each gene; values of zero have been replaced with 0.5) and lines indicate confidence intervals (black line – 
99.9%, orange line – 99% and blue line – 95%). Genes outside of these confidence intervals (light blue dots) are considered statistically different from the 
controls. Pearson correlation coefficients are shown in the upper left corner of each plot.
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Figure S4 - Heatmap showing differential gene expression across the various silver treatment libraries. 
This heatmap was created using all differentially expressed genes (adjusted P values < 0.05) using the 
pheatmap package in R/Bioconductor [16, 17]. The level of gene expression is visualized by using a colour 
gradient from dark blue (low expression) to dark red (high expression). The following code was used to 
generate the image: pheatmap(list_of_DEgenes, color = colorRampPalette(c("navy", "white", 
"firebrick3"))(50)).  
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Figure S5 – Gene Ontology (GO) terms over-represented in differentially expressed gene lists following exposure of zebrafish 
embryos to silver. DAVID was used to  identify over-representation of GO terms for Biological Processes, Cellular Components 
and Molecular Functions for lists of genes differentially expressed between each treatment and its control (adjusted P values < 
0.05), after 24 and 48h of exposure, using the list of all expressed genes as a background. Different shades of blue represent 
different statistical thresholds for over-representation: dark blue indicates P < 0.05 with Benjamini-Hochberg multiple test 
correction [18], medium and light blue indicate P < 0.01 and P < 0.05, respectively (without multiple-testing correction). For 
visualization purposes, only GO terms over-represented with P < 0.01 in at least one treatment were included. The numbers in 
each box indicate the total numbers of genes for each GO term among the list of differentially expressed genes for each 
treatment. The full dataset for GO analysis over-representation is presented in File S5. 
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Figure S5 (continued) 
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Table S2 – List of genes differentially expressed in a treatment-specific manner. 
Expression 
values 
(normalized 
counts per 
million) Fold change (+direction) Adjusted P values 
Treatment Ensembl Gene ID 24hpf 48hpf 24hpf 48hpf 24hpf 48hpf Gene symbol Gene Description 
Silver bulk ENSDARG00000069763 239 189 1.4 DOWN 1.5 DOWN 1.9E-02 6.5E-04 etv5a 
ETS translocation variant 5  [Source:RefSeq 
peptide;Acc:NP_001119933] 
Silver ions ENSDARG00000075016 53.3 17.8 2 UP 2.4 DOWN 9.8E-03 4.2E-02 A5WUQ7_DANRE 
Novel protein similar to vertebrate 
apolipoprotein B (Including Ag(X) antigen) 
(APOB) Fragment  
[Source:UniProtKB/TrEMBL;Acc:A5WUQ7] 
Silver ions ENSDARG00000012399 279 204 1.6 UP 1.5 UP 1.1E-06 1.1E-02 adssl 
adenylosuccinate synthase, like  
[Source:RefSeq peptide;Acc:NP_775344] 
Silver ions ENSDARG00000007413 42.6 22.4 5.5 DOWN 2.4 DOWN 6.2E-05 1.4E-02 arid2 
AT-rich interactive domain-containing protein 
2  [Source:RefSeq 
peptide;Acc:NP_001071231] 
Silver ions ENSDARG00000039515 189 99.6 2.3 DOWN 2 DOWN 1.8E-09 1.0E-06 atf4b1 
Cyclic AMP-dependent transcription factor 
ATF-4 (cAMP-dependent transcription factor 
ATF-4)(Activating transcription factor 4) 
[Source:UniProtKB/Swiss-Prot;Acc:Q6NW59] 
Silver ions ENSDARG00000014313 149 181 2.5 DOWN 1.5 DOWN 6.1E-08 7.2E-04 atp5j 
ATP synthase-coupling factor 6, mitochondrial  
[Source:RefSeq peptide;Acc:NP_998472] 
Silver ions ENSDARG00000045543 297 382 1.9 UP 1.3 UP 1.8E-14 1.9E-02 atp6v1f 
V-type proton ATPase subunit F  
[Source:RefSeq peptide;Acc:NP_001002526] 
Silver ions ENSDARG00000034961 154 100 3.1 DOWN 2.3 DOWN 4.5E-11 2.6E-11 bzw1b 
Basic leucine zipper and W2 domain-
containing protein 1-B  
[Source:UniProtKB/Swiss-Prot;Acc:Q803N9] 
Silver ions ENSDARG00000057013 41.1 117 3.3 DOWN 1.7 DOWN 1.5E-05 3.7E-04 cadm3 
cell adhesion molecule 3  [Source:RefSeq 
peptide;Acc:NP_001038711] 
Silver ions ENSDARG00000069093 94.4 163 3.3 DOWN 1.5 DOWN 2.1E-09 8.3E-03 col2a1a 
collagen alpha-1(II) chain  [Source:RefSeq 
peptide;Acc:NP_571367] 
Silver ions ENSDARG00000018002 82.2 161 2 DOWN 1.7 UP 3.4E-04 3.5E-03 dci 
Dci protein Fragment  
[Source:UniProtKB/TrEMBL;Acc:Q6DBW7] 
Silver ions ENSDARG00000012066 79.2 244 4 DOWN 1.4 UP 1.8E-07 2.9E-02 Dcn 
decorin  [Source:RefSeq 
peptide;Acc:NP_571772] 
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Silver ions ENSDARG00000020913 24.4 5.41 3.6 DOWN 4.6 DOWN 4.6E-03 1.0E-02 ddx56 
probable ATP-dependent RNA helicase DDX56  
[Source:RefSeq peptide;Acc:NP_001003876] 
Silver ions ENSDARG00000032653 3.05 20.1 17.9 DOWN 5.7 UP 9.1E-04 3.4E-02 fam60a 
family with sequence similarity 60, member A  
[Source:RefSeq peptide;Acc:NP_001020702] 
Silver ions ENSDARG00000062997 24.4 9.27 8.1 DOWN 3.2 DOWN 5.7E-04 3.0E-02 hyal2 
Novel protein similar to vertebrate 
hyaluronoglucosaminidase 2 (HYAL2) 
Fragment  
[Source:UniProtKB/TrEMBL;Acc:Q1LXC3] 
Silver ions ENSDARG00000041516 111 29.3 1.6 UP 2.4 DOWN 1.3E-03 1.9E-03 LOC100331938 - 
Silver ions ENSDARG00000058337 137 63.3 2.2 DOWN 1.7 DOWN 4.9E-07 3.5E-02 nop58 
NOP58 ribonucleoprotein homolog  
[Source:RefSeq peptide;Acc:NP_001009889] 
Silver ions ENSDARG00000020143 7.61 36.3 12.8 DOWN 2.8 UP 1.2E-02 4.2E-02 pah 
phenylalanine-4-hydroxylase  [Source:RefSeq 
peptide;Acc:NP_956845] 
Silver ions ENSDARG00000030638 32 93.5 2.7 DOWN 2.4 DOWN 5.4E-03 3.2E-12 pdlim7 
Pdlim7 protein  
[Source:UniProtKB/TrEMBL;Acc:Q6NWL9] 
Silver ions ENSDARG00000035146 95.9 66.4 1.7 DOWN 1.9 DOWN 1.6E-02 1.4E-03 polr2j 
polymerase (RNA) II (DNA directed) 
polypeptide J  [Source:RefSeq 
peptide;Acc:NP_001019571] 
Silver ions ENSDARG00000015474 22.8 27.8 2.6 DOWN 2.1 DOWN 1.6E-02 2.7E-02 ppp2r5ea 
protein phosphatase 2, regulatory subunit B', 
epsilon isoform a  [Source:RefSeq 
peptide;Acc:NP_919396] 
Silver ions ENSDARG00000027088 57.9 91.1 3.2 DOWN 1.6 DOWN 1.8E-05 2.3E-02 ptgds 
prostaglandin D2 synthase, brain  
[Source:RefSeq peptide;Acc:NP_998799] 
Silver ions ENSDARG00000052617 350 221 2.3 DOWN 1.5 DOWN 0.0E+00 1.9E-04 raver1 
ribonucleoprotein, PTB-binding 1  
[Source:RefSeq peptide;Acc:NP_001018503] 
Silver ions ENSDARG00000016088 42.6 37.1 1.8 UP 1.9 DOWN 3.5E-02 2.8E-02 rtn2a 
reticulon 2a  [Source:RefSeq 
peptide;Acc:NP_001025136] 
Silver ions ENSDARG00000013721 73.1 35.5 1.9 DOWN 2 DOWN 4.6E-03 2.2E-02 si:ch211-215l11.5 
im:6895556  [Source:RefSeq 
peptide;Acc:NP_001157278] 
Silver ions ENSDARG00000019231 28.9 49.4 3.5 DOWN 2.3 UP 1.7E-03 3.8E-02 spna2 
spectrin alpha chain, brain  [Source:RefSeq 
peptide;Acc:NP_001091958] 
Silver ions ENSDARG00000052712 1390 1420 2.1 UP 1.1 DOWN 2.4E-90 1.0E-02 suclg1 
succinyl-CoA ligase  [Source:RefSeq 
peptide;Acc:NP_001002577] 
Silver ions ENSDARG00000040031 393 342 3.4 DOWN 1.3 DOWN 0.0E+00 1.1E-02 tardbp 
TAR DNA-binding protein 43  [Source:RefSeq 
peptide;Acc:NP_958884] 
Silver ions ENSDARG00000031164 62.4 191 1.5 UP 2.5 UP 3.0E-02 2.9E-10 tuba8l2 
tubulin alpha-4A chain  [Source:RefSeq 
peptide;Acc:NP_956985] 
Silver ions ENSDARG00000078075 45.7 30.9 2.4 DOWN 2.1 DOWN 7.7E-03 2.5E-02 zgc:101577 Uncharacterized protein C6orf106 homolog  
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[Source:UniProtKB/Swiss-Prot;Acc:Q5BL31] 
Silver ions ENSDARG00000036834 888 71.8 2.1 DOWN 1.8 DOWN 0.0E+00 2.0E-03 zgc:109868 
cytokeratin-like  [Source:RefSeq 
peptide;Acc:NP_001017824] 
Silver ions ENSDARG00000037405 28.9 6.18 2 UP 3.8 DOWN 7.5E-03 3.4E-02 zgc:112083 
MBD2 (methyl-CpG-binding protein)-
interacting zinc finger protein  [Source:RefSeq 
peptide;Acc:NP_001017764] 
Silver ions ENSDARG00000038076 580 541 1.2 UP 1.2 DOWN 3.8E-02 3.4E-02 zgc:73345 
Reactive oxygen species modulator 1 (ROS 
modulator 1)(Protein MGR2 homolog) 
[Source:UniProtKB/Swiss-Prot;Acc:Q6NYD1] 
Silver NP ENSDARG00000077653 0 0 0 DOWN 0 DOWN 1.0E-03 2.9E-04 - - 
Silver NP ENSDARG00000019547 204 31.2 2 DOWN 6.7 DOWN 0.0E+00 0.0E+00 aaas 
aladin  [Source:RefSeq 
peptide;Acc:NP_998390] 
Silver NP ENSDARG00000020761 175 90.9 2.6 UP 2.3 UP 2.3E-09 2.1E-03 arrdc2 
arrestin domain-containing protein 2  
[Source:RefSeq peptide;Acc:NP_956233] 
Silver NP ENSDARG00000056258 20.5 1.36 3.6 DOWN 24.3 DOWN 9.9E-07 3.1E-05 cdc27 
cell division cycle protein 27 homolog  
[Source:RefSeq peptide;Acc:NP_958857] 
Silver NP ENSDARG00000045768 8.21 19 6.3 DOWN 4.3 DOWN 2.8E-07 1.1E-06 cry1a 
cryptochrome 1a isoform 2  [Source:RefSeq 
peptide;Acc:NP_571864] 
Silver NP ENSDARG00000035603 5.75 1.36 5.1 DOWN 13 DOWN 1.2E-03 3.0E-02 dao.2 
D-amino acid oxidase  [Source:RefSeq 
peptide;Acc:NP_999897] 
Silver NP ENSDARG00000027813 285 335 1.4 UP 1.4 UP 1.1E-02 8.9E-03 nus1 
Nogo-B receptor Precursor (NgBR)(Nuclear 
undecaprenyl pyrophosphate synthase 1 
homolog) [Source:UniProtKB/Swiss-
Prot;Acc:Q6DHR8] 
Silver NP ENSDARG00000009640 1550 2180 1.2 DOWN 1.3 UP 2.7E-06 1.4E-12 psmb1 
proteasome subunit beta type-1  
[Source:RefSeq peptide;Acc:NP_001003889] 
Silver NP ENSDARG00000017886 131 155 2 UP 1.9 UP 4.8E-04 1.1E-03 si:dkeyp-116g9.2 
Zinc finger protein ZNF-U69274  
[Source:UniProtKB/TrEMBL;Acc:Q6TNP6] 
Silver NP ENSDARG00000037965 326 274 1.7 UP 1.7 UP 1.2E-06 2.8E-04 srrm2 
Srrm2 protein  
[Source:UniProtKB/TrEMBL;Acc:Q503X8] 
Silver NP ENSDARG00000090442 237 129 3.6 UP 1.7 UP 4.7E-20 4.9E-02 wu:fc54d09 - 
Silver NP ENSDARG00000016830 208 236 1.7 UP 1.5 UP 1.5E-04 3.6E-02 zgc:92164 
Ribosomal protein S6 modification-like 
protein B  [Source:UniProtKB/Swiss-
Prot;Acc:Q66HZ2] 
Silver NP ENSDARG00000008218 92 115 2 DOWN 2 DOWN 2.6E-06 8.6E-06 znf410 
zinc finger protein 410  [Source:RefSeq 
peptide;Acc:NP_991216] 
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